See also this year's filing and all EDGAR filings for this company.
PDF Report 0001443863_2017_Biocorrx_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'NetIncome', 'value': -29705669, 'size_variable': 'Assets', 'size_value': 338899, 'ratio': 87.7, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001443863')"} |
Graph
Absolute values for 0001443863, Biocorrx Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 100,855 |
| 3 | PropertyPlantAndEquipment | 22,164 |
| 4 | remainder_Assets | 347,363 |
| 5 | LongTermLiabilities | 688,783 |
| 6 | LiabilitiesCurrent | 2,451,123 |
| 7 | remainder_Liabilities | 5,460,804 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 175,430 |
| 10 | GeneralAndAdministrativeExpense | 2,545,311 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 30,248 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 132,804 |
| 17 | remainder_Revenues | 701,772 |
| 18 | remainder_NetIncome | -3,721,961 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 470,382 |
| 1 | Liabilities | 8,600,710 |
| 2 | Expenses | 2,883,793 |
| 3 | Revenues | 701,772 |
| 4 | StockholdersEquity | -8,130,328 |
| 5 | NetIncome | -5,903,982 |
| 6 | ComprehensiveNetIncome | -5,903,982 |
| 7 | BaseVar | 8,189,309 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.90 |
| 9 | EconomicCapitalRatio | 0.0368 |
Edgar->Model Mapping
Feature Distribution
Change over Time
